Fundamentals

Valuation

Metric	Q3	Q4	Δ in %
EV/EBITDA	-393.57	-154.62	-31.33
Graham Fair Price	-8.25	792.79	864.04
PEG	52.09	-0.96	-2.01
Price/Book	15.31	0.75	0.65
Price/Cash Flow	inf	0.00	150.29
Prices/Earnings	50.60	18.05	11.98
Price/Sales	-4.24	12.52	13.07
Price/FCF	inf	0.00	150.29
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q3	Q4	Δ in %
Gross Profit Margin	0.00	1.00	1.00
Operating Margin	-100.00	< 0.005	0.40
ROA	-22.87	< 0.005	< 0.005
ROE	0.01	0.01	-23.43
ROIC	< 0.005	< 0.005	-99.99
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q3	Q4	Δ in %
Debt QOQ	0.29	0.02	1285.95
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-0.06	-1.00	-1603.48
EPS QOQ	-0.06	-0.19	-214.33
FCF QOQ	0.03	-1.00	3197.22
Revenue QOQ	< 0.005	0.26	22909.72
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q3	Q4	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	0.00	0.00	0.00
Days Sales Outstanding (DSO)	0.00	0.00	0.00
Inventory Turnover	0.00	0.00	0.00
Debt/Capitalization	0.79	0.74	-5.87
Quick Ratio	0.30	-2.62	770.89
Naive Interpretation	member

04 - Leverage & Liquidity · Bad

Fundamentals

Per Share Metrics

Metric	Q3	Q4	Δ in %
Book Value	1561.46	1637.34	4.86
Cash	5644.84	-6513.72	15.39
Capex	0.00	0.00	0.00
Free Cash Flow	6.78	0.00	inf
Revenue	77.90	98.36	26.27
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q3	Q4	Δ in %
Current Ratio	0.30	2.88	858.32
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-63.87	-503.52	-688.34
Naive Interpretation	Member

06 - Financial Health · Bad

Rating